Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19-Reference-Cited by-同舟云学术

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19

Published:2020-08 Issue:6 Volume:51 Page:595-597
ISSN:0188-4409
Container-title:Archives of Medical Research
language:en
Short-container-title:Archives of Medical Research

Author:

Saha Abinit,Sharma Ashish Ranjan,Bhattacharya Manojit,Sharma Garima,Lee Sang-Soo,Chakraborty Chiranjib

Publisher

Elsevier BV

Subject

General Medicine

Reference11 articles.

1. Clinical characteristics of 2019 novel coronavirus infection in China;Guan;N Engl J Med,2020

2. The 2019 novel coronavirus disease (COVID-19) pandemic: A zoonotic prospective;Chakraborty;Asian Pac J Trop Med,2020

3. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options;Chakraborty;Eur Rev Med Pharmacol Sci,2020

4. Nervous system involvement after infection with COVID-19 and other coronaviruses;Wu;Brain Behav Immun,2020

5. Management of corona virus disease-19 (COVID-19): the Zhejiang experience;Xu;J Zhejiang Univ Sci B,2020

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomaterials as a Versatile Tool for COVID-19 Treatment;BioNanoScience;2024-08-07

2. SARS-CoV-2 Omicron Spike shows strong binding affinity and favourable interaction landscape with the TLR4/MD2 compared to other variants;Journal of Genetic Engineering and Biotechnology;2024-03

3. Unlocking the potential of RNAi as a therapeutic strategy against infectious viruses: an in-silico study;Chemical Papers;2023-11-17

4. A brief overview of SARS-CoV-2 infection and its management strategies: a recent update;Molecular and Cellular Biochemistry;2023-09-24

5. SARS-CoV-2 Pandemic-Therapeutics in Warp Speed;Recent Advances in Anti-Infective Drug Discovery;2023-08